View all newsletters
Iovance Biotherapeutics’ tumour-infiltrating lymphocyte (TIL) therapy, lifileucel, continues to show promising results in advanced melanoma patients who have previously progressed…
By
[caption id="attachment_114468" align="aligncenter" width="285"] Huntington Solutions Vice President of Sales and Engineering, Travis Waters.[/caption] Huntington’s patented XDS™ product retains temperature…
Israeli biopharma company Mapi Pharma has decided to commission its manufacturing facility to help support the supply of Covid-19 vaccines…
Roche's Evrysdi (risdiplam) was approved earlier this year for infants with spinal muscular atrophy (SMA), reaching the market four years…
By
All the global markets, including the pharmaceutical sector, have faced considerable crisis amid the Covid-19 pandemic. However, innovative pharmaceutical companies…
By
Telemedicine is the use of electronic communication, such as videoconferencing or phone calls, for the delivery of remote clinical care…
By
OnAsset Intelligence, a provider of supply chain tracking and monitoring solutions, recently demonstrated that its Bluetooth Low Energy 5 (Bluetooth…
All women are at risk for cervical cancer. It is most commonly seen in women over age 30, with the…
By